Expression and possible role of interleukin-10 receptors in patients with adenomyosis
Other
OA: closed
CC0
⤵ 16 in-corpus citations
AI-generated summary
This study investigated the expression of interleukin-10 receptors in patients with adenomyosis to understand their potential role in the condition.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
OBJECTIVE: To investigate the expression and potential roles of interleukin-10 receptor 1 (IL-10R1) and interleukin-10 receptor 2 (IL-10R2) in adenomyosis.
STUDY DESIGN: This prospective study examined 33 women with histologically proven adenomyosis and 21 women without adenomyosis who had undergone hysterectomy for non-endometrial pathology. Comparative immunohistochemistry was used to evaluate the expression and localization of IL-10R1 and IL-10R2. Tissue sections were immunostained with goat anti-human interleukin-10 receptor alpha and rabbit anti-human interleukin-10 receptor beta antibodies. The presence and localization of IL-10R1 and IL-10R2 were evaluated microscopically throughout the menstrual cycle in eutopic and ectopic endometrial tissues of women with adenomyosis, and the results were compared with those for normal endometrium.
RESULTS: IL-10R1 and IL-10R2 were mainly expressed by epithelial cells in both women with adenomyosis and controls. Epithelial expression of IL-10R1 and IL-10R2 was higher in adenomyotic samples than in eutopic endometrium of women with adenomyosis or normal endometrium. Moreover, epithelial expression of IL-10R1 was higher in eutopic endometrium of women with adenomyosis than in normal endometrium. Epithelial expression of IL-10R1 showed cyclic variation in eutopic endometrium of women with adenomyosis and normal endometrium, with elevated expression in secretory-phase tissues compared with proliferative-phase tissues.
CONCLUSIONS: Intrinsic abnormalities concerning IL-10 and IL-10 receptors may be present in eutopic and ectopic endometria of women with adenomyosis. These findings suggest that IL-10 receptors may be involved in the immunotolerant and/or anti-inflammatory process of adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (31)
- Cytokine network of eutopic and ectopic endometrium in women with adenomyosis via openalex
- Decreased suppression of interleukin-6 after treatment with medroxyprogesterone acetate and danazol in endometrial stromal cells of women with adenomyosis via openalex
- Evidence for estrogen synthesis in adenomyotic tissues via openalex
- Inflammation in reproductive disorders via openalex
- Pathophysiology of adenomyosis via openalex
- Risk factors for adenomyosis via openalex
- W1993472421 via openalex
- W2013283905 via openalex
- W2017896938 via openalex
- W2019042264 via openalex
- W2023845407 via openalex
- W2028763115 via openalex
- W2029675712 via openalex
- W2058218898 via openalex
- W2083715429 via openalex
- W2097390476 via openalex
- W2097904070 via openalex
- W2102151740 via openalex
- W2114177134 via openalex
- W2131686775 via openalex
- W2134999383 via openalex
- W2154143583 via openalex
- W2204640292 via openalex
- W2285724160 via openalex
- W11141567 via openalex
- W6610406119 via openalex
- W287314825 via openalex
- W1511967417 via openalex
- W1944006756 via openalex
- W1987073290 via openalex
- W1993160730 via openalex
Cited by (16)
- Characterising the immune cell phenotype of ectopic adenomyosis lesions compared with eutopic endometrium: A systematic review 2023
- IL-10 is not anti-fibrotic but pro-fibrotic in endometriosis: IL-10 treatment of endometriotic stromal cells in vitro promotes myofibroblast proliferation and collagen type I protein expression 2022
- Mifepristone Inhibited the Expression of B7-H2, B7-H3, B7-H4 and PD-L2 in Adenomyosis 2021
- The new application of mifepristone in the relief of adenomyosis-caused dysmenorrhea 2020
- Expression and significance of T-cell immunoglobulin mucin molecule 3 and its ligand galectin-9 in patients with adenomyosis 2020
- Comparing Interleukin 10 (IL-10) Level in Women with Adenomyosis and without Adenomyosis 2019
- Current facts constituting an understanding of the nature of adenomyosis 2018
- Decreased expression of interleukin-37 in the ectopic and eutopic endometria of patients with adenomyosis 2017
- Molecular Characteristics of the Endometrium in Uterine Adenomyosis and Its Biochemical Microenvironment 2017
- Serum level concentrations of pro-inflammatory cytokines in patients with adenomyosis 2017
- Down-regulation of tumor suppressor PDCD4 expression in endometrium of adenomyosis patients 2016
- The Endometrium in Adenomyosis 2015
- Blocking IL-22, a potential treatment strategy for adenomyosis by inhibiting crosstalk between vascular endothelial and endometrial stromal cells 2015
- L-22 enhances the invasiveness of endometrial stromal cells of adenomyosis in an autocrine manner 2014
- Structural and molecular features of the endomyometrium in endometriosis and adenomyosis 2013
- The endometrium in adenomyosis 2012
Source provenance
- europepmc
- last seen: 2026-10-15T06:08:49.021275+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:09:51.187616+00:00
- unpaywall
- last seen: 2026-10-15T06:24:24.424788+00:00
License: CC0
· commercial use OK